Proposed Data Collections Submitted for Public Comment and Recommendations, 19913-19914 [2014-08012]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 69 / Thursday, April 10, 2014 / Notices
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–08013 Filed 4–9–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14OE]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
sroberts on DSK5SPTVN1PROD with NOTICES
Proposed Project
Monitoring and Reporting System for
the Rape Prevention and Education
Program Awardees—NEW—National
Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Sexual violence is a major public
health problem. According CDC’s
National Intimate Partner and Sexual
Violence Survey (NISVS, OMB# 0920–
0822), in the United States, nearly 1 in
VerDate Mar<15>2010
18:14 Apr 09, 2014
Jkt 232001
5 women and 1 in 71 men have been
raped in their lifetime, while 1 in 2
women and 1 in 5 men have
experienced severe sexual violence
victimization other than rape at some
point in their lives, with the majority of
victimization starting early in life.
According to NISVS, approximately
80% of female victims experienced their
first rape before the age of 25 and almost
half experienced the first rape before age
18. Among male victims, 28% were first
raped when they were 10 year old or
younger. NISVS also found that early
sexual victimization increases women’s
risk of adult victimization:
Approximately 35% of women who
were raped as minors were also raped as
adults compared to 14% of women
without an early rape history.
State health departments and the
community-based organizations funded
to implement sexual violence
prevention strategies have variable,
often low, levels of capacity and
infrastructure to engage in program
improvement and systematically collect
data about sexual violence as well as the
prevention strategies they are
implementing. Historically, some health
departments and funded communitybased organizations have not had
adequate resources to support a fulltime staff person to deliver and
implement prevention strategies.
Additionally, while sexual violence
prevention practitioners have
undergone a sea change and expanded
their focus from raising awareness of the
problem to implementing primary
prevention strategies, improved
implementation based on best-available
practices in prevention is still needed.
CDC, through the Rape Prevention
and Education (RPE) Program, supports
sexual violence prevention by
implementing primary prevention
strategies using a public health
approach and effective prevention
principles. The current cooperative
agreement will advance this goal by
supporting RPE funded organizations to
implement sexual violence prevention
strategies that adhere to general
principles of effective prevention
strategies. These principles include:
Addressing modifiable risk and
protective factors for perpetration and
victimization, addressing multiple
levels of the social ecology, emphasizing
primary prevention, having sufficient
dosage or intensity, being culturally
relevant, being developed and
implemented with stakeholders and
based on best available evidence.
Additionally, it aims to improve
program evaluation infrastructure and
capacity at the state level.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
19913
In order to accomplish these goals, the
program strategy involves the focused
implementation of three main
components:
Æ Component 1—Implementation and
program evaluation of sexual violence
(SV) prevention strategies using a public
health approach (this includes
expectations that program evaluation
activities are conducted at the state
level.
Æ Component 2—Provision of
Training and Technical Assistance to
RPE funded organizations on the
implementation of SV prevention
strategies.
Æ Component 3—Participation in
program support activities.
The primary outcome of interest is the
improved ability of RPE funded
organizations to use the public health
approach and effective prevention
principles to implement and evaluate
sexual violence prevention strategies.
CDC seeks a 3-year Office of
Management and Budget (OMB)
approval to collect information
electronically from awardees funded
under the RPE cooperative agreement.
Information will be collected from RPE
awardees through an electronic data
management information system; the
Rape Prevention and Education
Management Information System (RPE–
MIS). The RPE–MIS will be used to
collect information about the staffing
resources dedicated by each awardee, as
well as partnerships with external
organizations. The RPE–MIS requires
awardees to define their program
objectives in action-oriented SMART
(Specific, Measurable, Achievable,
Relevant, and Time-Framed) format,
identify their target population and
associated strategies citing the best
available evidence and data sources,
establish the link between their
objectives, chosen strategies and the
target population, and provide
quantifiable performance measures
associated with the chosen strategies.
Information collected through the RPE–
MIS will be used to inform performance
monitoring, and program evaluation.
Anticipated respondents are a
maximum of 55 awardees for the RPE
Program. All respondents will be state
and territorial health departments or
designated personnel from their partner
sexual assault coalitions. The time
commitments for data entry and training
are greatest during the initial population
of the RPE–MIS, typically in the first six
months of implementation. Estimated
burden for the first-time population of
the RPE–MIS is fifteen hours. Annual
Reporting is estimated at three hours per
respondent.
E:\FR\FM\10APN1.SGM
10APN1
19914
Federal Register / Vol. 79, No. 69 / Thursday, April 10, 2014 / Notices
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN TO RESPONDENTS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
State and Territorial Health Departments or Sexual Assault Coalition
Designee.
RPE–MIS: Initial population .............
55
1
15
825
RPE–MIS: Annual reporting .............
55
1
3
165
...........................................................
........................
........................
........................
990
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
[FR Doc. 2014–08012 Filed 4–9–14; 8:45 am]
Proposed Project
BILLING CODE 4163–18–P
FoodNet Non-O157 Shiga ToxinProducing E. coli Study: Assessment of
Risk Factors for Laboratory-Confirmed
Infections and Characterization of
Illnesses by Microbiological
Characteristics (0920–0905 expires 11/
30/14)—Extension—National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0905]
sroberts on DSK5SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Leroy Richardson 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
VerDate Mar<15>2010
18:14 Apr 09, 2014
Jkt 232001
Background and Brief Description
Each year many Shiga toxinproducing E. coli (STEC) infections
occur in the United States, ranging in
severity from mild diarrhea, to
hemorrhagic colitis and in some cases,
life-threatening hemolytic uremic
syndrome (HUS). HUS occurs most
frequently following infection with
serogroup O157; 6% of patients with
this type of STEC infection develop
HUS, with highest occurrence in
children aged < 5 years. HUS has a
fatality rate of approximately 5%; up to
25% of HUS survivors are left with
chronic kidney damage. STEC are
broadly categorized into two groups by
their O antigens, STEC O157 and nonO157 STEC. The serogroup O157 is
most frequently isolated and most
strongly associated with HUS. Risk
factors for STEC O157 infections in the
United States and internationally have
been intensely studied. Non-O157 STEC
are a diverse group that includes all
Shiga toxin-producing E. coli of
serogroups other than O157. Over 50
STEC serogroups are known to have
caused human illness. Numerous nonO157 outbreaks have been reported from
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
throughout the world and clinical
outcomes in some patients can be as
severe as those seen with STEC O157
infections, however, little is known
about the specific risk factors for
infections due to non-O157 STEC
serogroups. More comprehensive
understanding of risk factors for
sporadic non-O157 STEC infections is
needed to inform prevention and
control efforts.
The FoodNet case-control study is the
first multistate investigation of nonoutbreak-associated non-O157 STEC
infections in the United States. It
investigates risk factors for non-O157
STEC infections, both as a group and
individually for the most common nonO157 STEC serogroups. In addition, the
study characterizes the major known
virulence factors of non-O157 STEC to
assess how risk factors and clinical
features vary by virulence factor
profiles. As the largest, most
comprehensive, and most powerful
study of its kind, it is making an
important contribution towards better
understanding of non-O157 STEC
infections and will provide sciencebased recommendations for
interventions to prevent these
infections. Study enrollment began
between July and September 2012 (sites
had staggered start dates) and is
scheduled to run for 36 months. Since
we have not yet enrolled enough cases
to meet the study objectives, we are
requesting an extension.
Persons with non-O157 STEC
infections who are identified as part of
routine public health surveillance and
randomly selected healthy persons in
the patients’ communities (to serve as
controls) are contacted and offered
enrollment into this study. Participation
is completely voluntary and there is no
cost for enrollment. The total burden is
268 hours.
E:\FR\FM\10APN1.SGM
10APN1
]]>Agencies
[Federal Register Volume 79, Number 69 (Thursday, April 10, 2014)]
[Notices]
[Pages 19913-19914]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08012]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-14OE]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Monitoring and Reporting System for the Rape Prevention and
Education Program Awardees--NEW--National Center for Injury Prevention
and Control (NCIPC), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Sexual violence is a major public health problem. According CDC's
National Intimate Partner and Sexual Violence Survey (NISVS,
OMB 0920-0822), in the United States, nearly 1 in 5 women and
1 in 71 men have been raped in their lifetime, while 1 in 2 women and 1
in 5 men have experienced severe sexual violence victimization other
than rape at some point in their lives, with the majority of
victimization starting early in life. According to NISVS, approximately
80% of female victims experienced their first rape before the age of 25
and almost half experienced the first rape before age 18. Among male
victims, 28% were first raped when they were 10 year old or younger.
NISVS also found that early sexual victimization increases women's risk
of adult victimization: Approximately 35% of women who were raped as
minors were also raped as adults compared to 14% of women without an
early rape history.
State health departments and the community-based organizations
funded to implement sexual violence prevention strategies have
variable, often low, levels of capacity and infrastructure to engage in
program improvement and systematically collect data about sexual
violence as well as the prevention strategies they are implementing.
Historically, some health departments and funded community-based
organizations have not had adequate resources to support a full-time
staff person to deliver and implement prevention strategies.
Additionally, while sexual violence prevention practitioners have
undergone a sea change and expanded their focus from raising awareness
of the problem to implementing primary prevention strategies, improved
implementation based on best-available practices in prevention is still
needed.
CDC, through the Rape Prevention and Education (RPE) Program,
supports sexual violence prevention by implementing primary prevention
strategies using a public health approach and effective prevention
principles. The current cooperative agreement will advance this goal by
supporting RPE funded organizations to implement sexual violence
prevention strategies that adhere to general principles of effective
prevention strategies. These principles include: Addressing modifiable
risk and protective factors for perpetration and victimization,
addressing multiple levels of the social ecology, emphasizing primary
prevention, having sufficient dosage or intensity, being culturally
relevant, being developed and implemented with stakeholders and based
on best available evidence. Additionally, it aims to improve program
evaluation infrastructure and capacity at the state level.
In order to accomplish these goals, the program strategy involves
the focused implementation of three main components:
[cir] Component 1--Implementation and program evaluation of sexual
violence (SV) prevention strategies using a public health approach
(this includes expectations that program evaluation activities are
conducted at the state level.
[cir] Component 2--Provision of Training and Technical Assistance
to RPE funded organizations on the implementation of SV prevention
strategies.
[cir] Component 3--Participation in program support activities.
The primary outcome of interest is the improved ability of RPE
funded organizations to use the public health approach and effective
prevention principles to implement and evaluate sexual violence
prevention strategies.
CDC seeks a 3-year Office of Management and Budget (OMB) approval
to collect information electronically from awardees funded under the
RPE cooperative agreement. Information will be collected from RPE
awardees through an electronic data management information system; the
Rape Prevention and Education Management Information System (RPE-MIS).
The RPE-MIS will be used to collect information about the staffing
resources dedicated by each awardee, as well as partnerships with
external organizations. The RPE-MIS requires awardees to define their
program objectives in action-oriented SMART (Specific, Measurable,
Achievable, Relevant, and Time-Framed) format, identify their target
population and associated strategies citing the best available evidence
and data sources, establish the link between their objectives, chosen
strategies and the target population, and provide quantifiable
performance measures associated with the chosen strategies. Information
collected through the RPE-MIS will be used to inform performance
monitoring, and program evaluation.
Anticipated respondents are a maximum of 55 awardees for the RPE
Program. All respondents will be state and territorial health
departments or designated personnel from their partner sexual assault
coalitions. The time commitments for data entry and training are
greatest during the initial population of the RPE-MIS, typically in the
first six months of implementation. Estimated burden for the first-time
population of the RPE-MIS is fifteen hours. Annual Reporting is
estimated at three hours per respondent.
[[Page 19914]]
There are no costs to respondents other than their time.
Estimated Annualized Burden to Respondents
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
State and Territorial Health RPE-MIS: Initial 55 1 15 825
Departments or Sexual Assault population.
Coalition Designee.
RPE-MIS: Annual 55 1 3 165
reporting.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 990
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-08012 Filed 4-9-14; 8:45 am]
BILLING CODE 4163-18-P
